Cargando…
In Vivo Evaluation of Dual-Targeted Nanoparticles Encapsulating Paclitaxel and Everolimus
A synergistic combination of paclitaxel (PTX) and everolimus (EVER) can allow for lower drug doses, reducing the toxicities associated with PTX, while maintaining therapeutic efficacy. Polymeric nanoparticles (NPs) of high stability provide opportunities to modify the toxicity profile of the drugs b...
Autores principales: | Houdaihed, Loujin, Evans, James Christopher, Allen, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628352/ https://www.ncbi.nlm.nih.gov/pubmed/31146485 http://dx.doi.org/10.3390/cancers11060752 |
Ejemplares similares
-
Pharmacokinetics and biodistribution of negatively charged pectin nanoparticles encapsulating paclitaxel
por: Verma, Anita K., et al.
Publicado: (2013) -
Preparation of Paclitaxel-Encapsulated Bio-Functionalized Selenium Nanoparticles and Evaluation of Their Efficacy against Cervical Cancer
por: Menon, Soumya, et al.
Publicado: (2022) -
Co-Encapsulation of Paclitaxel and JQ1 in Zein Nanoparticles as Potential Innovative Nanomedicine
por: Celano, Marilena, et al.
Publicado: (2022) -
Preparation, Characterization, and in Vitro/in Vivo
Evaluation of Paclitaxel-Bound Albumin-Encapsulated Liposomes for
the Treatment of Pancreatic Cancer
por: Okamoto, Yuko, et al.
Publicado: (2019) -
Bortezomib‐Encapsulated Dual Responsive Copolymeric Nanoparticles for Gallbladder Cancer Targeted Therapy
por: Chen, Mingyu, et al.
Publicado: (2022)